Equal-WT
WhaleScore 2.0
?
Soleus Capital Management is based out of Greenwich. Soleus Capital Management is a hedge fund with 9 clients and discretionary assets under management (AUM) of $1,471,425,810 (Form ADV from 2023-03-15). Their last reported 13F filing for Q4 2023 included $901,249,517 in managed 13F securities
and a top 10 holdings concentration of 45.07%. Soleus Capital Management's largest holding is Teva Pharmaceutical Industries Ltd, ADR with shares held of 5,564,440. Whalewisdom has at least 18 13F filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
RYZB RayzeBio Inc. | 4.23% |
HCA HCA Healthcare Inc | 3.05% |
IDYA Ideaya Biosciences I | 2.23% |
PEN Penumbra Inc | 2.22% |
GSKw GSK Plc | 2.1% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
XBI SPDR(R) S&P(R) Biote (CALL) | 8.42% |
PODD Insulet Corp | 1.88% |
EOLS Evolus Inc | 1.75% |
CRL Charles River Labora | 1.74% |
AXSM Axsome Therapeutics | 1.53% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
TEVA Teva Pharmaceutical | 6.45% |
UTHR United Therapeutics | 6.09% |
GSKw GSK Plc | 5.26% |
RYZB RayzeBio Inc. | 5.15% |
EDAP EDAP TMS S.A. ADR | 4.23% |
2023-12-31
13F Activity
Market Value | $0.90b, Prior: $1.08b |
New Purchases | 16 stocks |
Added To | 16 stocks |
Sold out of | 34 stocks |
Reduced holdings in | 34 stocks |
Top 10 Holdings % | 45.07% |
Turnover %[1] | 68.49% |
Turnover Alt %[2] | 21.42% |
Time Held Top 20 | 3.55 quarters |
Time Held Top 10 | 2.8 quarters |
Time Held All | 4.52 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31